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IntroductIon
Autophagy involves sequestration of cytosolic material into 
double-membrane vesicles termed autophagosomes, which 
subsequently fuse with the lysosome, leading to the degra-
dation and recycling of the contents. A role for autophagy in 
the mucosal barrier is suggested by the genetic association be-
tween ATG16L1 and small intestinal Crohn’s disease, a major 
form of inflammatory bowel disease (IBD; Wlodarska et al., 
2015; Cadwell, 2016). ATG16L1 is part of a complex that lip-
idates the ubiquitin-like molecule LC3 to promote autopha-
gosome formation and function. The risk allele of ATG16L1 
associated with IBD susceptibility (ATG16L1T300A) introduces 
a caspase-cleavage site that destabilizes the protein product 
and reduces autophagy in the presence of TNFα (Lassen et al., 
2014; Murthy et al., 2014). How decreased autophagy relates 
to the intestinal barrier dysfunction and inflammation char-
acteristic of IBD is under intense investigation.
One mechanism by which autophagy supports via-
bility and counters inflammation is through the removal of 
cytotoxic material such as depolarized mitochondria that 
produce ROS (Mariño et al., 2014; Cadwell, 2016). Consis-
tent with this prosurvival function, induction of autophagy 
by cytosolic HMGB1 in the intestinal epithelium is asso-
ciated with protection from apoptosis (Zhu et al., 2015). 
However, autophagy is essential for salivary gland tissue 
degradation during Drosophila melanogaster development 
(Berry and Baehrecke, 2007) and mediates cell death in 
stressed neurons in Caenorhabditis elegans and mammals 
(Samara et al., 2008; Liu et al., 2013). In transformed cells, 
autophagy can facilitate a form of regulated necrosis termed 
necroptosis that is triggered by TNFα or other inflamma-
tory signals (Chen et al., 2011). The autophagosome serves 
as a scaffold for the necroptosis signaling complex upon de-
letion of Map3k7, a tumor suppressor gene commonly mu-
tated in prostate cancer (Goodall et al., 2016). Necroptosis 
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occurs when receptor-interacting serine-threonine kinase 
1 (RIPK1) and RIPK3 interact and activate mixed-lineage 
kinase domain–like protein (MLKL; Zhang et al., 2009; 
Sun et al., 2012). MLKL has been suggested to execute 
necroptosis through regulation of mitochondrial fission, 
but this mechanism has been contested (Pasparakis and 
Vandenabeele, 2015). Adding to this confusion, mitochon-
drial degradation through autophagy (mitophagy) can pro-
mote or prevent necroptosis in animal models of chronic 
obstructive pulmonary disease and ischemia/reperfusion 
injury, respectively (Mizumura et al., 2014; Lu et al., 2016). 
Therefore, the intersection among autophagy, mitochon-
drial homeostasis, and necrotic cell death is complex and 
potentially cell type dependent.
We previously demonstrated that murine norovirus 
(MNV) infection of mice with a germline gene-trap mu-
tation in Atg16L1 (Atg16L1HM mice; HM, hypomorph) 
induces morphological and functional defects in Paneth 
cells (Cadwell et al., 2008, 2010), antimicrobial epithelial 
cells in the small intestinal crypt (Vaishnava et al., 2008; 
Adolph et al., 2013). This observation in MNV-infected 
Atg16L1HM mice led us to identify similar Paneth cell de-
fects in resection specimens from Crohn’s disease patients 
homozygous for the ATG16L1T300A risk allele (Cadwell et 
al., 2008). Also, MNV-infected Atg16L1HM mice display 
additional pathologies when treated with dextran sodium 
sulfate (DSS), such as blunted villi in the small intestine 
(Cadwell et al., 2010). The persistent strain of MNV that 
induces these intestinal abnormalities in Atg16L1HM mice 
does not typically induce disease in immunocompetent 
mice. In fact, we recently showed that MNV infection pro-
motes intestinal development and protects against injury 
in antibiotic-treated WT C57BL/6 (B6) mice from DSS 
(Kernbauer et al., 2014). An outstanding question is why an 
otherwise beneficial enteric virus induces disease patholo-
gies when autophagy is reduced.
In addition to this virally triggered model of IBD, 
Atg16L1HM mice are susceptible to graft-versus-host dis-
ease (GVHD) after allogeneic hematopoietic stem cell 
transplantation (allo-HSCT), a procedure used to treat ma-
lignant and nonmalignant blood disorders (Hubbard-Lucey 
et al., 2014). Notably, the same ATG16L1T300A allele linked 
to IBD is associated with poor survival after allo-HSCT 
in humans (Holler et al., 2010; Hubbard-Lucey et al., 
2014). TNFα blockade ameliorates disease in both the vi-
rally triggered IBD and the GVHD models in Atg16L1HM 
mice (Cadwell et al., 2010; Hubbard-Lucey et al., 2014). 
Thus, it is possible that preventing TNFα-induced pathol-
ogy is a conserved function of autophagy in these two 
disease conditions. To understand the role of ATG16L1 
and the autophagy machinery in dampening inflamma-
tion at the mucosal barrier, we investigated the mecha-
nisms by which ATG16L1 plays a cytoprotective function 
in the intestinal epithelium in both the virally triggered 
IBD and GVHD models.
resuLts
AtG16L1 in the epithelium protects against exacerbated 
intestinal injury after MnV infection
Given that MNV behaves similarly to symbiotic bacteria in 
WT B6 mice (Kernbauer et al., 2014), the virally triggered 
IBD model may reveal mechanisms involved in tolerat-
ing the presence of microbes in the gut. However, the cell 
type-specific function of ATG16L1 in this model has not 
been investigated. Autophagy in intestinal epithelial cells 
(IECs) is critical for protection against Salmonella enterica 
Typhimurium and secretion of antimicrobial molecules and 
mucin (Adolph et al., 2013; Benjamin et al., 2013; Conway et 
al., 2013; Patel et al., 2013). Thus, we examined susceptibility 
of Atg16L1f/f;villin-Cre mice in which Atg16L1 is deleted 
in IECs (Atg16L1ΔIEC) to DSS treatment in the presence or 
absence of MNV. Atg16L1ΔIEC mice receiving MNV+DSS 
displayed higher lethality and clinical disease score compared 
with similarly treated littermate Atg16L1f/f mice and unin-
fected groups (Fig. 1, A and B). MNV-infected Atg16L1ΔIEC 
mice, but not uninfected mice, displayed blunted villi in the 
small intestine and a decrease in Paneth cells (Fig. 1, C and 
D). In contrast, there was no significant difference in gob-
let cells even in the presence of MNV infection (Fig. S1 A). 
Atg16L1ΔIEC mice displayed more severe colon histopathol-
ogy compared with Atg16L1f/f mice regardless of MNV in-
fection; however, shortening of colon length was particularly 
striking in Atg16L1ΔIEC mice infected with MNV (Fig. 1, E 
and F). Additionally, analyses of a panel of cytokines indicated 
that TNFα was increased in sera of Atg16L1ΔIEC mice in an 
MNV-dependent manner (Fig. S1 B). MNV burden was sim-
ilar in Atg16L1ΔIEC and Atg16L1f/f mice (Fig. S1 C). Therefore, 
these results raise the possibility that deletion of Atg16L1 sen-
sitizes IECs to the inflammatory response to the virus.
deletion of Atg16L1 in the intestinal 
epithelium worsens GVHd
Next, we wished to validate this role of ATG16L1 in IECs 
in a second model of intestinal inflammation. GVHD is 
often accompanied by a compromised intestinal barrier 
(Hill and Ferrara, 2000). To elicit GVHD, we used an an-
imal model of allo-HSCT similar to our previous study 
(Hubbard-Lucey et al., 2014) in which bone marrow (BM) 
cells with or without T cells from B10.BR donor mice 
were transplanted into lethally irradiated Atg16L1ΔIEC 
mice, which are on the B6 background. Compared with 
Atg16L1f/f recipients, Atg16L1ΔIEC mice receiving BM 
and 2 × 106 T cells displayed increased mortality and clin-
ical GVHD score (Fig.  2, A and B). Mice that received 
BM without T cells did not display this severe lethality 
(Fig. 2 A), supporting the T cell dependence of the model. 
Because of the rapid course of the disease, we sacrificed 
the recipients on day 4 after allo-HSCT for all of our fur-
ther analyses. We found that Atg16L1ΔIEC mice displayed 
exacerbated small intestinal and colonic histopathology 
and a decrease in colon length (Fig. 2, C–E). Atg16L1ΔIEC 
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Figure 1. AtG16L1 in the epithelium protects against intestinal injury after MnV infection. (A and B) Survival (A) and clinical disease score (B) of 
Atg16L1f/f (f/f ) and Atg16L1ΔIEC (ΔIEC) mice treated with 5% DSS ± MNV infection. n = 22 (f/f ), 11 (ΔIEC), 16 (f/f + MNV), and 19 (ΔIEC + MNV). (C and D) 
Representative H&E images of small intestine harvested from mice treated as in A and quantification of villi length (C) and Paneth cells (yellow arrowheads; 
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mice showed more lymphocytic infiltration in the crypts, 
apoptotic glandular epithelial cells, and crypt regeneration 
compared with Atg16L1f/f recipients in the small intes-
tine (Fig.  2 C). In addition, the number of Paneth cells, 
but not goblet cells, in Atg16L1ΔIEC mice was significantly 
decreased compared with Atg16L1f/f recipients (Fig. 2, F 
and G). The number of CD4+ and CD8+ T cells, dendritic 
cells, B220+ B cells, and CD11b+ granulocytes in the lam-
ina propria of the small intestine and colon were similar 
in Atg16Lf/f and Atg16L1ΔIEC recipients (Fig. S1, D–K). 
TNFα was readily detectable in the sera of both recipients, 
and IFN-γ was significantly increased in Atg16L1ΔIEC mice 
(Fig. S1 L). Collectively, these results indicate that Atg16L1 
deletion in IECs was sufficient to confer increased suscep-
tibility in models of IBD and allo-HSCT, and the rapid 
lethality observed in Atg16L1ΔIEC allo-HSCT recipients 
does not correlate with obvious differences in the mag-
nitude of cell-mediated immune mediators that are typ-
ically associated with GVHD. Instead, these results raise 
the possibility that ATG16L1 deficiency enhances ep-
ithelial tissue damage.
AtG16L1 protects against epithelial cell death
We next examined markers of epithelial turnover in in-
testinal tissue harvested from the above mice. In the 
MNV+DSS model, there was a striking increase in IECs 
positive for the proliferation marker Ki-67 in Atg16L1ΔIEC 
compared with Atg16Lf/f mice (Fig.  3, A and B). Addi-
tionally, a large number of IECs in Atg16L1ΔIEC mice were 
positive for terminal deoxynucleotidyl transferase–medi-
ated dUTP nick-end labeling (TUN EL; Fig. 3, A and B), 
indicative of cell death. TUN EL staining was striking in 
the crypt-base of the small intestine, where Paneth cells are 
located (Ramanan and Cadwell, 2016). In contrast, we did 
not observe a similar degree of staining with the apoptosis 
marker cleaved caspase-3 (CC3; Fig. 3, A and B). There was 
also an increase in IECs positive for Ki-67 and TUN EL 
in Atg16L1ΔIEC mice compared with Atg16Lf/f mice in 
the allo-HSCT model (Fig.  3 C). The number of CC3+ 
cells were modest and did not overlap with the TUN EL 
staining, which was again enriched in the crypt-base 
(Fig. 3 C). Thus, ATG16L1 has a critical role in IEC ho-
meostasis in both the virally triggered IBD model and 
the GVHD model. The enrichment of TUN EL+ cells in 
the absence of a similar increase in CC3 staining in the 
Atg16L1ΔIEC intestines raises the possibility that ATG16L1 
prevents a nonapoptotic form of cell death (Gold et al., 
1994; Grasl-Kraupp et al., 1995; Imagawa et al., 2016).
AtG16L1 is necessary for viability of intestinal organoids
To examine the mechanism by which ATG16L1 maintains 
IECs, we derived organoids from small intestinal crypts har-
vested from Atg16L1f/f and Atg16L1ΔIEC mice. A previous 
study reported that Atg16L1 mutant Paneth cells have re-
duced capacity to promote organoid formation when cocul-
tured with Lgr5+ stem cells (Lassen et al., 2014). Consistent 
with this finding, we found that organoids generated from 
Atg16L1ΔIEC mice were smaller and contained fewer buds 
compared with those generated from Atg16L1f/f mice (Fig. 4, 
A–C). Although the number of crypts isolated from each gen-
otype were similar, and ATG16L1 deficiency had little effect 
on the expression of the stem cell marker Lgr5 (Fig. S2, A and 
B), we observed that up to 40% of the Atg16L1ΔIEC organoids 
lost viability over time on the basis of their collapsed structure 
and complete absence of buds (Fig. 4 D). Propidium iodide 
(PI) uptake and lactate dehydrogenase (LDH) release assays 
confirmed that an increased amount of cell death occurs in 
Atg16L1ΔIEC organoids (Fig. 4 E and Fig. S2 C). Loss in via-
bility of ATG16L1-deficient organoids, but not those derived 
from control mice, was significantly exacerbated when cul-
tured in the presence of TNFα (Fig. 4 D). Live imaging anal-
yses showed that Atg16L1ΔIEC organoids rapidly take up PI 
in the media upon exposure to TNFα (Fig. 4 F and Video 1). 
These findings indicate that ATG16L1 is necessary for sur-
vival of intestinal organoids and resistance to TNFα.
It is possible that the reason why some Atg16L1ΔIEC 
organoids die in the absence of exogenous TNFα adminis-
tration is that low levels of TNFα are produced by the or-
ganoids. Indeed, TNFα was detectable in the supernatant of 
Atg16L1ΔIEC organoids in the absence of exogenous TNFα 
administration (Fig.  4  G). Anti-TNFα antibodies improved 
viability of Atg16L1ΔIEC organoids from 60% to 80% and 
had no effect on Atg16L1f/f organoids (Fig. 4 H). Thus, At-
g16L1ΔIEC organoids spontaneously produce factors, includ-
ing TNFα, that mediate cell death. In sharp contrast to these 
findings with organoids derived from the small intestine, the 
viability of Atg16L1f/f and Atg16L1ΔIEC organoids derived 
from the colon was similar, even upon addition of exogenous 
TNFα (Fig. S2, D and E).
The observation that Atg16L1ΔIEC colonic organoids 
remain viable in the presence of TNFα may be related to 
the lack of Paneth cells in the colon. Thus, we examined 
the effect of Atg16L1 deletion on Paneth cells in small 
intestinal organoids. Paneth cells were quantified by light 
microscopy in day 5 cultures, a time point at which a suf-
ficient number of intact Atg16L1ΔIEC organoids can be an-
alyzed. We found that the absolute number of Paneth cells, 
D). At least 50 villi and crypts were quantified per mouse. n = 9 (f/f ), 9 (ΔIEC), 6 (f/f + MNV), and 6 (ΔIEC + MNV). (E and F) Representative H&E images of 
colon and quantification of colon histopathology (E) and colon length (F) from mice treated as in A. n = 13 (f/f ), 13 (ΔIEC), 15 (f/f + MNV), and 13 (ΔIEC 
+ MNV). (C–E) Bars: 100 µm (C and E); 20 µm (D). Data points represent individual mice in B, E, and F, individual villi in C, and individual crypts in D. Bars 
represent mean ± SEM, and at least two independent experiments were performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Mantel-Cox in 
A and one-way ANO VA and Tukey’s test in B–F.
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Figure 2. deletion of Atg16L1 in the intestinal epithelium of allo-Hsct recipients worsens GVHd. (A) Survival of lethally irradiated Atg16L1f/f (f/f ) 
and Atg16L1ΔIEC (ΔIEC) mice transplanted with 5 × 106 T cell–depleted BM cells with or without 2 × 106 splenic T cells from donor B10.BR mice. n = 5 (f/f, BM 
only), 6 (ΔIEC, BM only), 13 (f/f, BM + T cells), and 15 (ΔIEC, BM + T cells). (B–E) Mice receiving BM and T cells from B10.BR mice as in A were sacrificed 4 d 
after allo-HSCT and analyzed for macroscopic signs of GVHD (B; see Materials and methods). Representative images of H&E-stained sections and pathology 
score of small intestine (C) and colon (D) and quantification of colon length (E). n = 10 mice per group. (F) Representative higher magnification H&E images 
from C and quantification of Paneth cells (yellow arrowheads). n = 5 mice per group. At least 50 crypts were quantified per mouse. (G) Quantification of 
goblet cells from sections in C stained with periodic acid–Schiff (PAS)/Alcian blue of the small intestine. At least 50 villi were quantified per mouse. n = 5 
mice per group. (C, D, and F) Bars: 200 µm (C and D); 20 µm (F). Data points present individual mice in B–E, individual crypts in F, and individual villi in G. 
Bars represent mean ± SEM, and at least two independent experiments were performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Mantel-Cox 
in A and Mann-Whitney U test in B–G.
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as well as the proportion of Paneth cells normalized to total 
epithelial cells, were significantly reduced in Atg16L1ΔIEC 
organoids compared with Atg16L1f/f organoids (Fig.  4, 
I and K). The addition of TNFα the day before analysis 
reduced Paneth cell numbers further in Atg16L1ΔIEC or-
ganoids (Fig. 4, I and K). Immunofluorescence analysis of 
the Paneth cell granule protein lysozyme confirmed that 
TNFα treatment led to an almost complete loss of these 
cells in Atg16L1ΔIEC organoids (Fig. 4  J). In contrast, the 
proportion of goblet cells normalized to total cells was 
similar between the genotypes (Fig. 4, L and M). We noted 
that ATG16L1 deficiency decreased the absolute number 
of goblet cells, but this finding is likely a reflection of the 
smaller size of Atg16L1ΔIEC organoids (Fig. 4, B and C). 
Also, TNFα treatment increased rather than decreased gob-
let cell numbers in Atg16L1ΔIEC organoids. Thus, Paneth 
cells in Atg16L1ΔIEC organoids are preferentially sensitive 
to TNFα-induced depletion.
AtG16L1 protects small intestinal 
organoids from necroptosis
Similar to the findings in vivo, Atg16L1ΔIEC organoids treated 
with TNFα displayed a high proportion of TUN EL+ cells rel-
ative to CC3+ cells; TUN EL and CC3 staining were both 
low in TNFα-treated Atg16L1f/f organoids (Fig. 5, A and B). 
Rather than improve viability, the apoptosis (pan-caspase) in-
hibitor Z-VAD-FMK exacerbated cell death in Atg16L1ΔIEC 
organoids (Fig.  5, C and D). Cells displaying morphology 
consistent with necrotic cell death, such as discontinuous 
plasma membrane and swelling of organelles, were detected 
in Atg16L1ΔIEC organoids treated with Z-VAD-FMK by 
transmission electron microscopy (TEM) analyses (Fig. 5 E 
Figure 3. AtG16L1 protects against cell 
death in the small intestinal epithelium. 
(A and B) Representative images (A) and 
quantification of Ki-67, TUN EL, and CC3 
staining (B) of small intestine harvested from 
MNV-infected Atg16L1f/f (f/f ) and Atg16L1ΔIEC 
(ΔIEC) mice on day 15 after MNV infection. 
Arrowheads indicate IECs positive for the in-
dicated markers. Bars, 20 µm for TUN EL and 
50 µm for Ki-67 and CC3 staining. At least 50 
crypt–villus units were quantified per mouse 
from three mice per group. (C) Ki-67-, TUN EL-, 
and CC3-positive IECs were quantified as in B 
in small intestinal sections from Atg16L1f/f and 
Atg16L1ΔIEC mice on day 4 after allo-HSCT. At 
least 50 crypt–villus units were quantified per 
mouse from five mice per group. Data points 
in B and C represent individual crypts. Bars 
represent mean ± SEM, and at least two inde-
pendent experiments were performed. ***, P < 
0.001; ****, P < 0.0001 by unpaired t test.
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Figure 4. AtG16L1 is necessary for the survival of intestinal organoids and Paneth cells. (A–C) Representative images of small intestinal organoids 
derived from Atg16L1f/f (f/f ) and Atg16L1ΔIEC (ΔIEC) mice on the indicated days of culture (A). Area (B) and bud number (C) were quantified on day 7. At 
least 20 organoids were quantified from three mice each. (D) Viability of organoids on the basis of morphology (see Fig. S2 C) ± 20 ng/ml TNFα. n ≥ 10 
mice each. (E) LDH cytotoxicity of organoids on day 2 quantified by LDH release assay. n = 3 mice each. (F) Time-series images corresponding to Video 1 in 
which organoids were treated with 20 ng/ml TNFα at time 0 in the presence of PI (red). Digits represent hours :minutes. Representative of three independent 
repeats. (G) Quantification of TNFα in culture supernatants from D on day 3. n = 11 per group. (H) Viability of organoids ± 20 µg/ml anti-TNFα antibody. 
n = 3 mice each. (I–K) Representative H&E images (I) and immunofluorescence images (J) of lysozyme (red) and DAPI (blue) of organoids on day 5. TNFα was 
added on day 4. Triangles indicate Paneth cells in I. (K) Total number of Paneth cells (left), total number of IECs (middle), and frequency of Paneth cells 
normalized to total IECs (right) were quantified from images in I. At least 20 organoids were quantified from three mice each. (L and M) Representative 
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and Fig. S3 A). These results suggest that ATG16L1 deficiency 
increases susceptibility to nonapoptotic cell death.
In contrast to pyroptosis mediated by caspase-1, 
Z-VAD-FMK promotes necroptosis by preventing caspase-8 
from functioning as a negative regulator of RIPK1/3 signaling 
(Hitomi et al., 2008; Kaiser et al., 2011; Oberst et al., 2011). 
We found that decreased viability of Atg16L1ΔIEC organoids 
treated with Z-VAD-FMK was reversed by the RIPK1 in-
hibitor Necrostatin-1 (Nec-1; Degterev et al., 2005; Fig. 5 C). 
TNFα-induced cell death in Atg16L1ΔIEC organoids was also 
rescued by Nec-1 (Fig. 5, F and G). We next examined the 
effect of Ripk3 and Mlkl knockdown (KD) using two differ-
ent hairpins per target gene introduced by lentiviral transduc-
tion. Wnt-3a was added to the culture media to facilitate the 
lentiviral transduction procedure, which we confirmed did 
not alter the effect of TNFα on Atg16L1ΔIEC organoids (Fig. 
S3 B). Atg16L1ΔIEC organoids transduced with the Ripk3 or 
Mlkl shRNAs, but not control shRNA, displayed improved 
survival in the presence of TNFα (Fig. 5, H and I; and Fig. S3, 
C–F). These results indicate that TNFα induces necroptosis 
in Atg16L1ΔIEC organoids.
AtG16L1 protects intestinal organoids from necroptosis by 
maintaining mitochondrial homeostasis
Autophagy has been shown to mediate the degradation of 
caspase-8 to inhibit TRA IL-mediated apoptosis in a colorec-
tal cancer cell line (Hou et al., 2010). However, we did not 
detect a convincing difference in RIPK1, RIPK3, MLKL, or 
caspase-8 levels when comparing Atg16L1f/f and Atg16L1ΔIEC 
organoids (Fig. S4 A). Instead, we detected an increase in phos-
phorylated-RIPK3 (p-RIP3) and p-MLKL in Atg16L1ΔIEC 
organoids after TNFα treatment (Fig. S4 A). These results 
are consistent with a model in which ATG16L1 prevents 
enhanced signaling rather than degradation of the RIPK3/
MLKL complex. The limited availability of protein that can 
be harvested from organoids precluded biochemical analyses 
of additional posttranslational modifications or protein inter-
actions, and thus, we pursued other potential mechanisms that 
can explain the role of ATG16L in epithelial viability.
Removal of damaged mitochondria is a well-established 
function of autophagy (Randow and Youle, 2014). Therefore, 
we examined mitochondria in the ultrastructural images from 
Fig. 5 E. In these analyses, we did not discriminate between 
different cell types because there was an insufficient number 
of Paneth cells in Atg16L1ΔIEC for quantification. Atg16L1ΔIEC 
epithelial cells contained a high proportion of morphologi-
cally aberrant mitochondria that are swollen and missing cris-
tae, which was exacerbated by the addition of Z-VAD-FMK 
(Fig. 6 A). Atg16L1ΔIEC organoids also contained a higher de-
gree of staining with the fluorescent mitochondrial superoxide 
indicator MitoSOX in their epithelium, especially after treat-
ment with TNFα (Fig. 6 B). To determine the contribution 
of elevated ROS to loss in viability, we treated organoids with 
the antioxidant N-acetyl-l-cysteine (NAC). NAC reduced 
MitoSOX staining and improved survival of TNFα-treated 
Atg16L1ΔIEC organoids and even improved survival of un-
stimulated Atg16L1ΔIEC organoids (Fig.  6, B and C). These 
results suggest that mitochondrial ROS accumulation con-
tributes to the impaired survival of Atg16L1ΔIEC organoids.
Next, we examined whether disruption of mitochon-
dria is sufficient to confer sensitivity to necroptosis. WT B6 
organoids treated with the mitochondrial uncoupler carbonyl 
cyanide m-chlorophenylhydrazone (CCCP) displayed im-
paired survival that was exacerbated by TNFα (Fig. 6 D). In 
contrast, organoids derived from Ripk3−/− mice displayed a 
modest decrease in viability only after 4 d of adding CCCP 
and TNFα in the culture (Fig. 6 D). We next examined the 
effect of Parkin (Park2) deletion on organoid survival. Parkin 
is an E3 ligase that ubiquitinates mitochondrial outer mem-
brane proteins to mediate selective degradation through au-
tophagy (Randow and Youle, 2014). Park2−/− organoids were 
susceptible to TNFα-induced death, which was rescued by 
Nec-1 addition (Fig. 6 E). Additionally, knocking down an-
other autophagy gene, Atg7, also led to impaired survival in 
the presence of TNFα, which was rescued by Nec-1 (Fig. S4, 
B and C). These data indicate that genetic or chemical disrup-
tion of autophagy and mitochondrial homeostasis can confer 
susceptibility to necroptosis in IECs.
To determine whether the disease variant of ATG16L1 
confers sensitivity to cell death, we examined organoids gen-
erated from Atg16L1T316A knock-in mice harboring the mu-
rine equivalent of the human risk allele (Murthy et al., 2014). 
Atg16L1T316A organoids treated with TNFα displayed a loss 
in viability that was prevented by Nec-1 (Fig. 7 A). In ad-
dition, TNFα treatment caused a decrease in Paneth cells in 
Atg16L1T316A organoids that was not observed in the WT B6 
controls (Fig. 7 B). Moreover, Atg16L1T316A mice were sus-
ceptible to lethality after MNV+DSS treatment (Fig. 7 C). 
These data support the relevance of our model to genetic 
susceptibility underlying Crohn’s disease.
tnFα and rIPK1 inhibition ameliorates disease 
in AtG16L1-deficient mice
We examined whether anti-TNFα antibody or RIPK1 inhi-
bition prevent cell death in vivo and ameliorate disease. Con-
sistent with our hypothesis, administration of TNFα-blocking 
images of goblet cells (triangles) in periodic acid–Schiff (PAS)/Alcian blue staining of organoids from I (L) and quantification of total number of goblet cells 
(left), total number of IECs (middle), and frequency of Paneth cells normalized to total IECs (right; M). At least 20 organoids were quantified from three mice 
each. (A, F, I, J, and L) Bars: 100 µm (A); 50 µm (F, I, J, and L). Data points in B, C, G, K, and M represent individual organoids, and data points in D, E, and H 
are mean of three technical replicates. Bars represent mean ± SEM, and at least two independent experiments were performed. *, P < 0.05; **, P < 0.01; ***, 
P < 0.001; ****, P < 0.0001 by unpaired t test in B, C, D, E, G, and H and one-way ANO VA and Tukey’s test in K and M.
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Figure 5. AtG16L1 inhibits necroptosis in intestinal organoids. (A and B) Representative images and quantification of TUN EL+ (A) and CC3+ (B) cells 
per organoid on day 5 normalized to total IEC. TNFα was added on day 4. At least 20 organoids were quantified from three mice each. (C and D) Quanti-
fication of viability (C) and representative images of organoids (D) from Atg16L1f/f and Atg16L1ΔIEC mice on day 5 ± Z-VAD-FMK (Z-VAD) and Nec-1. (E) 
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antibodies led to 100% survival of Atg16L1ΔIEC mice receiv-
ing MNV+DSS, eliminated all signs of morbidity, reduced cell 
death, and restored Paneth cell numbers (Fig. 8, A–E). This 
finding likely reflects a function of RIPK1 signaling down-
stream of TNFα because administration of the RIPK1 inhib-
itor Nec-1s (Takahashi et al., 2012) reduced TUN EL+ cells 
in the crypts of Atg16L1ΔIEC mice and restored Paneth cell 
numbers to levels similar to Atg16L1f/f mice (Fig. S5, A and 
B). To determine whether RIPK1 represents a target for ther-
apeutic intervention, we tested a newly generated necroptosis 
inhibitor with improved specificity for RIPK1, GSK547. We 
confirmed the efficacy of GSK547 in blocking necropto-
sis in vitro (Fig. S5 C) and found that it rescues survival of 
Atg16L1ΔIEC mice treated with MNV+DSS (Fig.  8, F–H). 
These data indicate that ATG16L1 has a critical cytoprotec-
tive function in vitro and in vivo in the presence of TNFα.
dIscussIon
We found that Atg16L1 deletion in IECs is sufficient to exac-
erbate disease in models of IBD and GVHD and is associated 
with a defect in epithelial turnover marked by a reduction in 
Paneth cell numbers. In the IBD model, disease was depen-
dent on MNV, likely reflecting the as yet poorly understood 
immune response to this intestinal virus, which includes 
production of TNFα and other cytokines (McCartney et al., 
2008; Kim et al., 2011; Fang et al., 2013). The dependence of 
MNV is a critical aspect of our findings given our previous 
observation that MNV is an otherwise beneficial virus (Kern-
bauer et al., 2014). How animal viruses affect host physiol-
ogy beyond their roles as pathogens remains obscure, and our 
knowledge of the long-term impact of intestinal viruses is far 
behind that of symbiotic bacteria (Cadwell, 2015). Our results 
support the paradigm that context, such as host genotype, de-
termine whether a given infectious agent has a beneficial or 
adverse effect on the host.
The cytoprotective function of ATG16L1 was re-
produced remarkably well in intestinal organoids, allowing 
us to gain insight into the underlying cell biological basis 
of our observations. Several findings in this in vitro model 
indicate that ATG16L1 is blocking necroptosis rather than 
apoptosis or pyroptosis: death of ATG16L1-deficient or-
ganoids is exacerbated by Z-VAD-FMK, loss of viability 
occurs in the absence of caspase-3 cleavage, and survival is 
rescued by blocking RIPK1, RIPK3, or MLKL. Consistent 
with these observations, blocking TNFα or RIPK1 in vivo in 
MNV+DSS-treated ATG16L1-deficient mice reduces epi-
thelial cell death, restores Paneth cell numbers, and amelio-
rates disease. Additional mechanistic experiments are required 
to characterize the in vivo cell death modality and the specific 
role of Paneth cells. Other groups have shown that depletion 
of Paneth cells can occur in a manner dependent on RIPK3, 
and that Crohn’s disease patients display RIPK3+ Paneth cells 
in the small intestine (Günther et al., 2011; Simmons et al., 
2016). Our observation that organoids and mice harboring 
the Atg16L1 risk variant reproduce observations made with 
complete Atg16L1 deficiency provides a strong rationale for 
pursuing future in vivo experiments that link our findings to 
these observations in the literature and offers an opportunity 
to identify pathogenesis events that are specific to this geno-
type as a way to segregate patients.
The link between necroptosis in ATG16L1-deficient 
organoids and mitochondrial ROS is supported by a recent 
study showing that Pink1 deleted fibroblasts, which are defi-
cient in mitophagy, display increased ROS and susceptibility 
to Z-VAD-FMK–induced cell death (Lu et al., 2016). How-
ever, mitochondria are dispensable for necroptosis in T cells 
treated with Z-VAD-FMK and TNFα (Tait et al., 2013). A 
critical difference between our system and many of the other 
experimental models is that we can induce necroptosis with 
TNFα in the absence of Z-VAD-FMK; other studies investi-
gating necroptosis typically use caspase-8 inhibition to shunt 
the cell death pathway away from apoptosis. It remains possible 
that when caspase-8 is intact, mitochondrial ROS contribute 
to necroptosis by altering signaling. ROS and TNFα signal-
ing are known to have a complex bidirectional relationship, 
and ROS can alter activation of molecules without affecting 
their total levels (Blaser et al., 2016). This potential mecha-
nism would be consistent with findings demonstrating that 
mitochondria do not function downstream of MLKL during 
necroptosis (Wang et al., 2012; Murphy et al., 2013; Remijsen 
et al., 2014). Also, it is unlikely that TNFα functions alone in 
vivo. Interferons (both type I and IFN-γ) are notable because 
they are associated with viral infections, display significant 
crosstalk with autophagy, and trigger necroptosis (Pasparakis 
and Vandenabeele, 2015; Cadwell, 2016). Animal models of 
GVHD indicate that interferons can either promote or ame-
liorate inflammation (Blazar et al., 2012; Fischer et al., 2017). 
We suggest that organoid cultures can help deconvolute the 
intersection between these key inflammatory cytokines and 
ROS activity in the epithelium.
Our findings also contrast with studies demonstrating a 
role for autophagy in promoting necroptosis in cancer cells. In 
prostate cells in which autophagy promotes RIPK1-MLKL 
interaction and necroptosis, deletion of the tumor suppressor 
Representative TEM images of organoids on day 3. Z-VAD was added on day 0. Stars indicate lumen side of organoid, and arrows indicate Paneth cell. (F 
and G) Quantification of viability (F) and representative images of organoids (G) from Atg16L1f/f and Atg16L1ΔIEC mice on day 5 ± TNFα and Nec-1. (H and I) 
Viability of Atg16L1ΔIEC organoids transduced with lentiviruses encoding shRNAs targeting Ripk3 (H) and Mlkl (I) or a nonspecific control, ±TNFα. (A, B, D, E, 
and G) Bars: 50 µm (A and B); 100 µm (D and G); 2 µm (E). Data points in A and B represent individual organoids, and data points in C, F, H, and I are mean 
of three technical replicates. Bars represent mean ± SEM, and at least two independent experiments were performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
****, P < 0.0001 by one-way ANO VA and Tukey’s test in A and B and unpaired t test in C, F, H, and I.
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Figure 6. AtG16L1 protects intestinal organoids from necroptosis by maintaining mitochondrial homeostasis. (A) Representative TEM images of 
mitochondria classified into type 1 (cristae are maintained), type 2 (mildly swollen and a moderate decrease in the number of visible cristae), and type 3 
(severely swollen and >70% of cristae are missing, or highly dysmorphic and electron dense). At least 20 cells in each organoid were analyzed per group 
from three mice each. (B) Representative fluorescent images of organoids on day 3 treated ± TNFα and NAC and stained with MitoSOX Red. Quantification 
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Map3k7 is necessary for sensitization to necroptosis (Goodall 
et al., 2016), suggesting that autophagy may have a distinct 
role in cell viability during tumorigenesis. To our knowledge, 
we are the first to investigate this pathway in a primary 3D 
culture model, which may explain why we found that auto-
phagy has an inhibitory effect on necroptosis.
Although we found that Atg7 KD or Park2 deletion 
renders organoids susceptible to TNFα-induced necroptosis, 
it remains possible that ATG16L1 has functions outside of 
mitophagy that contribute to cell death. Recent studies have 
provided compelling evidence that intestinal inflammation 
occurs when IRE1α mediates unresolved ER stress down-
stream of ATG16L1 deletion in Paneth cells (Adolph et al., 
2013; Diamanti et al., 2017; Tschurtschenthaler et al., 2017). 
The findings presented here indicate that disruption in mito-
chondrial homeostasis in Paneth cells is another deleterious 
consequence of ATG16L1 deficiency, which likely synergizes 
with ER stress. ER stress has been implicated in necroptosis 
(Saveljeva et al., 2015). Also, with the emergence of uncon-
ventional forms of autophagy (i.e., autophagy-related path-
ways), it will be important to consider functions of ATG16L1 
that are independent of known roles of autophagy. Elucidat-
ing the detailed molecular intersection between ATG16L1 
and necroptosis in IECs will be an important future direction.
Our study establishes an intimate relationship between 
the ATG16L1 risk allele, necrotic cell death, and Paneth cell 
dysfunction, all of which have been independently linked to 
IBD. Additionally, our findings indicate that this three-way 
relationship may apply to GVHD as well. Improvements 
in the specificity of necroptosis inhibitors will allow us to 
test the efficacy of therapeutically targeting this pathway in 
these disease models and may ultimately lead to new treat-
ment options in patients.
MAterIALs And MetHods
Mice
Age- and gender-matched 6–12-wk-old mice on the 
C57BL/6J (B6) background were used. Atg16L1f/f;villinCre 
(Atg16L1ΔIEC) and littermate control Atg16L1f/f mice were 
generated for experiments by crossing Cre-positive and 
Cre-negative mice provided by S. Virgin (Washington Uni-
versity School of Medicine, St. Louis, MO). B6, B10.BR, and 
Park2−/− mice were purchased from The Jackson Laboratory 
and bred onsite to generate animals for experimentation. 
RIP3−/− mice were provided by G. Miller (NYU School 
of Medicine, New York, NY). Atg16L1T316A mice were pro-
vided by M. van Lookeren Campaigne (Genentech). All ani-
mal studies were performed according to approved protocols 
by the New York University School of Medicine and Me-
morial Sloan Kettering Cancer Center Institutional Animal 
Care and Use Committees.
Virally triggered disease model
MNV CR6 concentrated stock was prepared as described 
(Cadwell et al., 2010; Kernbauer et al., 2014). Mice were in-
fected orally by pipette with 3 × 106 PFUs resuspended in 
25 µl PBS. Plaque assay was used to quantify viral burden 
in 2 cm of ileum or colon as previously described (Kernbauer 
et al., 2014). On day 10 postinfection, mice were administered 
5% DSS (TdB Consultancy) in their drinking water for 6 d, 
which was replaced by regular drinking water for the remain-
der of the experiment. Mice were injected i.p. with 1 mg of 
either anti-TNFα (XT3.1) or IgG1 isotype control (HRPN) 
antibodies (Bio X Cell) 1 d before DSS treatment and re-
ceived subsequent injections of 0.5 mg every 3 d. Mice were 
fed with chow containing 0.833 g/kg GSK547 from day 7 to 
day 19 or injected i.p. with Nec-1s (4 mg/kg; BioVision) or 
7% DMSO (Fisher BioReagents) every day from day 9 to day 
14. Clinical disease score was quantified on the basis of five 
parameters, including diarrhea (0–2), hunched posture (0–2), 
fur ruffling (0 or 1), mobility (0–2), and blood stool (0–1), in 
which eight was the maximum score for the pathology.
Hematopoietic stem cell transplantation
Allo-HSCTs were performed as previously described (Hub-
bard-Lucey et al., 2014) with 1,100-cGy split-dosed irradi-
ation of recipients transplanted with 5 × 106 BM cells after 
T cell depletion with anti-Thy-1.2 and low-TOX-M rabbit 
complement (Cedarlane Laboratories). Donor T cells were 
prepared by harvesting splenocytes and enriching T cells by 
Miltenyi MACS purification of CD5 (routinely >90% pu-
rity). Recipient mice were monitored daily for survival, and 
clinical GVHD was quantified at the time of sacrificing mice 
for five clinical parameters (weight loss, hunched posture, ac-
tivity, fur ruffling, and skin lesions) on a scale from 0 to 2. A 
clinical GVHD score was generated by the summation of the 
five criteria as previously described (Cooke et al., 1998).
Intestinal organoids
Small intestinal crypts were isolated and cultured as described 
previously (Sato et al., 2009). In brief, crypts of proximal small 
intestine were counted and embedded in 30 µl of Matrigel 
(Corning) at 10,000 crypts/ml and cultured in DMEM/F-12 
(Thermo Fisher Scientific) in the presence of 100 IU pen-
icillin and 100 µg/ml streptomycin (Corning), 125 µg/ml 
gentamicin (Gibco), 2 mM l-glutamine (Corning), 20 ng/ml 
of MitoSOX mean fluorescence intensity (MFI) in the epithelium shown. Staining in the lumen was excluded. At least 20 organoids were quantified from 
three mice each. (C–E) Viability of organoids from Atg16L1f/f and Atg16L1ΔIEC mice treated ± TNFα and NAC (C), B6 and Rip3−/− mice treated ± TNFα and 
CCCP (D), and B6 and Park2−/− mice treated ± TNFα and Nec-1 (E). n = 3 mice each. (A and B) Bars: 0.5 µm (A); 50 µm (B). Data points in B represent indi-
vidual organoids, and data points in C–E are mean of three technical replicates. Bars represent mean ± SEM, and at least two independent experiments were 
performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by one-way ANO VA and Tukey’s test in B and unpaired t test in C–E.
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mEGF (PeproTech), 100 ng/ml mNoggin (R&D Systems), 
and 500 ng/ml mR-Spondin 1 (R&D Systems), hereafter 
referred as ENR medium. Surface area of organoids was 
quantified with ImageJ (National Institutes of Health). Co-
lonic crypts were isolated and cultured as described previ-
ously (Sato et al., 2011; Yui et al., 2012). Crypts of colon were 
counted and embedded in Matrigel and cultured in the ENR 
medium plus 50 ng/ml Wnt-3a, 1× B-27, and N-2 supple-
ment (Thermo Fisher Scientific). For viability assays, crypts 
were embedded in 10  µl Matrigel at 5,000 crypts/ml and 
cultured in 96-well culture plate in triplicate with or with-
out 50 µM Z-VAD-FMK (ApexBio), 20 µM Nec-1 (Sigma- 
Aldrich), 20 ng/ml mTNFα (PeproTech), 20 µg/ml anti- 
TNFα antibody (R&D Systems), 100  µM NAC (Sigma- 
Figure 7. the AtG16L1 risk variant is associated with loss of intestinal organoid viability and virally triggered disease. (A and B) Viability of 
organoids from B6 and Atg16L1T316A (T316A) mice treated ± TNFα and Nec-1. n = 3 mice each (A). Representative H&E images and quantification of Paneth 
cells per organoid on day 7 normalized to total IECs (B). TNFα was added on day 0. Arrowheads indicate Paneth cells. At least 20 organoids were analyzed 
from three mice each. Bars, 50 µm. (C) Survival of B6 and Atg16L1T316A (T316A) mice treated with 5% DSS ± MNV infection. n = 8 (f/f ), 8 (T316A), 9 (f/f + 
MNV), and 16 (T316A + MNV). Data points in A are mean of three technical replicates, and data points in B represent individual organoids. Bars represent 
mean ± SEM, and at least two independent experiments were performed. *, P < 0.05; **, P < 0.01 by unpaired t test in A, one-way ANO VA and Tukey’s test 
in B, and Mantel-Cox in C.
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Figure 8. tnFα and rIPK1 inhibition ameliorates disease in AtG16L1-deficient mice. (A) Schematic representation of anti-TNFα treatment in 
MNV+DSS model. (B and C) Survival of Atg16L1f/f (f/f ) and Atg16L1ΔIEC (ΔIEC) mice treated with anti-TNFα or isotype control antibodies were monitored 
for survival (B) and clinical disease score (C) on day 16. n = 7 (f/f, isotype), 9 (ΔIEC, isotype), 7 (f/f, anti-TNF), and 10 (ΔIEC, anti-TNF). (D and E) Number of 
TUN EL+ (D) and Paneth (E) cells per crypt on day 15 in mice treated ± anti-TNFα. At least 50 crypts were quantified from three mice per group. (F) Schematic 
representation of GSK547 treatment in MNV+DSS model. (G and H) Atg16L1f/f and Atg16L1ΔIEC mice treated with either GSK547 or control chow were mon-
itored for survival (G) and clinical disease score on day 16 (H). n = 8 (f/f, control), 9 (ΔIEC, control), 9 (f/f, GSK547), and 10 (ΔIEC, GSK547). Data points in C 
and H represent individual mice, and data points in D and E represent individual crypts. Bars represent mean ± SEM, and at least two independent experi-
ments were performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Mantel-Cox in B and G and one-way ANO VA and Tukey’s test in C–E and H.
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Aldrich), and 400 nM GSK547 (GlaxoSmithKline). For 
CCCP treatment, organoids were prepared from small inte-
sitnal crypts in a manner similar to other experiments except 
on day 5 were mechanically dissociated into crypt domains 
by pipetting and cultured with or without 5  µM CCCP 
(Sigma-Aldrich) and 20 ng/ml mTNFα. Percentage viable 
organoids was determined by daily quantification of the num-
ber of intact organoids. Opaque organoids with condensed 
structures or those that have lost adherence were excluded. 
Dead organoids were marked by staining with 100 µg/ml PI 
(Sigma-Aldrich) and 100 µg/ml Hoechst 33342 (Invitrogen). 
LDH release was measured by harvesting supernatant from 
organoid cultures on day 2 and using CytoTox-ONE Homo-
geneous Membrane Integrity Assay (Promega) according to 
the manufacturer’s protocol. Mitochondrial ROS were mea-
sured by staining day 3 organoids with MitoSOX Red for 
live-cell imaging (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. The mean fluorescence intensity in 
the epithelium of at least 20 organoids were analyzed using 
ImageJ software (National Institutes of Health).
Histology and immunohistochemistry
Quantification of all microscopy data were performed blind. 
Intestinal sections were prepared and stained with H&E and 
periodic acid–Schiff/Alcian blue as previously described 
(Cadwell et al., 2010; Kernbauer et al., 2014). Villus height 
was quantified for at least 50 villi per mouse in ileal sections 
that were cut perpendicular to the villus-crypt axis as de-
fined by the presence of a visible crypt lumen from the orifice 
to the base of the crypt, thereby minimizing tissue orien-
tation-based artifacts (Cadwell et al., 2010). Colon histopa-
thology was scored by Y.D. by grading semiquantitatively as 0 
(no change) to 4 (most severe) for the following inflamma-
tory lesions: severity of chronic inflammation, crypt abscess, 
and granulomatous inflammation; and for the following ep-
ithelial lesions: hyperplasia, mucin depletion, ulceration, and 
crypt loss (Leach et al., 1996). Intestinal GVHD was scored 
by C.L. as previously described (Hubbard-Lucey et al., 2014). 
For immunohistochemistry, formalin fixed paraffin-embed-
ded sections were deparaffinized online and antigen retrieved 
in Ventana Cell Conditioner 2 (Citrate). Endogenous per-
oxidase activity was blocked with hydrogen peroxide. Un-
conjugated polyclonal rabbit anti-mouse CC3 (asp-175; Cell 
Signaling Technology) and unconjugated rabbit anti-mouse 
Ki67 (SP7; Lab Vision) were used, and both Ki-67 and CC3 
were detected with anti-rabbit, HRP-conjugated multimer 
and visualized with 3,3-diaminobenzidene and enhanced 
with copper sulfate. TUN EL staining was performed using 
the In situ Cell Death Detection POD kit (Roche Diagnos-
tics) on the Discovery XT according to the manufacturer’s 
protocol. Appropriate positive and negative controls were 
run in parallel to study sections. At least 50 crypts per mouse 
were observed to count CC3+, Ki-67+ cells, and TUN EL+ 
cells. For intestinal organoids, frozen sections were prepared 
by fixing with 4% paraformaldehyde (Electro Microscopy 
Sciences) and cryoprotecting with 20% sucrose (Sigma- 
Aldrich). Fixed organoids were mixed with NEG-50 (Thermo 
Fisher Scientific) and frozen in cryomold with 2-methyl-
butane (Themo Fisher Scientific) cooled by dry ice. 5-µm 
sections were made by Cryostat (Micron HM350; Thermo 
Fisher Scientific). The sections were air-dried overnight at 
room temperature and then stained with anti–Lysozyme C 
(C-19; Santa Cruz) and followed by the secondary Alexa 
Fluor 594 (Invitrogen) antibody. At least 20 organoids were 
observed per sample to count TUN EL+, CC3+, Paneth, and 
goblet cells in organoids. Histology and immunohistochem-
istry samples were analyzed using Zeiss Axioplan with Spot 
camera. Bright-field/fluorescent images and video imaging of 
live organoids were performed using a Zeiss AxioObserver.
Z1 with EC Plan-Neofluar 10×/0.30 lens, FL Filter Set 43 
HE Cy3, and Axiocam 503 Mono operated with Zen Blue 
software. For live video imaging, 20 ng/ml mTNFα and 100 
µg/ml PI were added before imaging, and time-lapse images 
of multiple fields were collected at 5-min intervals over 19 h. 
Images were processed and quantified using ImageJ.
Immunoblotting
Small intestinal organoids at day 3 were stimulated with 20 
ng/ml mTNFα for 2  h, then organoids were incubated in 
lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% 
Triton X-100, 10% glycerol, and 1× Halt protease and phos-
phatase inhibitor cocktail; Thermo Fisher Scientific) on ice 
for 20 min and centrifuged at 14,000 g for 20 min. Samples 
were resolved on Bolt 4%–12% Bis-Tris Plus Gels (Invitro-
gen) and transferred to polyvinylidene fluoride membranes. 
The following antibodies were used for immunoblotting 
studies: anti–β-actin (AC-15; Sigma-Aldrich), anti–Phos-
pho-MLKL (Ser345) and anti-MLKL (Cell Signaling), anti- 
RIP3 (phospho S232; Abcam), anti-RIP3 (AHP1797; AbD 
Serotec), anti–caspase-8 (1G12; Enzo Life Sciences), anti-RIP 
(D94C12; Cell Signaling Technology), and anti-Atg16L 
(Sigma-Aldrich). Secondary antibodies (mouse anti–rabbit 
[211-032-171], goat anti–mouse [115-035-174], and goat 
anti–rat [112-035-175], respectively) were purchased from 
Jackson Laboratories, and IRDye 680RD goat anti–rabbit 
IgG (925-68071) and IRDye 800CW goat anti–mouse IgG 
(925-32210) were purchased from LI-COR.
Flow cytometry and cytokine analyses
Antibodies were obtained from BD Biosciences PharMingen 
(CD8 and CD11c), and BioLegend (CD4, CD11b, B220, and 
I-AE). Cells were stained for 20 min at 4°C in PBS with 0.5% 
BSA (PBS/BSA) after Fc block, washed, and resuspended in 
DAPI (Sigma-Aldrich) in PBS/BSA to exclude dead cells. 
Flow cytometry was performed on an LSR II (BD Biosci-
ences) and analyzed with FlowJo (Tree Star Software). For 
cytokine quantification, blood was collected into microcen-
trifuge tubes, allowed to clot, and centrifuged, and the serum 
was collected. ProcartaPlex Multiplex Immunoassay was 
conducted per the manufacturer’s instructions (Affymetrix). 
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Results were acquired with a Luminex 200 instrument and 
analyzed with xPON ENT software (Luminex Corporation).
Lentivirus infection and gene Kd
RIPK3 shRNA (TRCN0000022536 and 
TRCN0000022534), MLKL shRNA (TRCN0000022602 
and TRCN0000022599), ATG7 shRNA 
(TRCN0000375444), and nontarget shRNA control 
(SHC016) constructs were purchased from Sigma-Aldrich. 
Each lentiviral construct along with lentiviral packaging 
mix (pLP1, pLP2, and VSVG; Sigma-Aldrich) was cotrans-
fected into 293FT cells using Lipofectamine 3000 (Thermo 
Fisher Scientific) according to the manufacturer’s protocol, 
then the supernatant containing lentivirus was harvested and 
concentrated using Lenti-X concentrator (Clontech). The 
transduction procedure was adapted from a previously de-
scribed method (Koo et al., 2011). In brief, organoids from 
Atg16L1ΔIEC mice were cultured in antibiotic-free ENR me-
dium for 5 d, and at day 3 the medium was changed to ENR 
plus 50 ng/ml Wnt-3a (R&D Systems) and 10 mM nico-
tinamide (Sigma-Aldrich). The organoids were mechanically 
dissociated into single cells by pipetting, and the fragments 
were incubated with TrypLE Express (Gibco) for 5 min at 
37°C and centrifuged at 1000 g for 5 min. The cell clusters 
were combined with viral suspension containing the ENR 
growth factors and 50 ng/ml Wnt-3a, 10 mM nicotinamide, 
10 µM Y-27632 dihydrochloride (Sigma-Aldrich), and 8 µg/
ml Polybrene (Millipore). The cells were transferred into 48-
well culture plate, and the plate was centrifuged at 600 g at 
32°C for 60 min. Finally, the cells were embedded in 30 µl 
of Matrigel and cultured in 24-well plate in antibiotic- 
free ENR medium containing Wnt-3a, nicotinamide, and 
Y-27632 dihydrochloride. 2 d after infection the medium 
was changed to ENR plus Wnt-3a with or without mTNFα.
transmission electron microscopy
Intestinal organoids at day 3 were fixed with 2.5% glu-
taraldehyde, 2% paraformaldehyde in 0.1 M sodium cac-
odylate buffer, pH 7.2, for 2  h and postfixed with 1% 
osmium tetroxide for 1.5  h at room temperature, then 
processed in a standard manner and embedded in EMbed 
812 (Electron Microscopy Sciences). Semithin sections 
were cut at 1 mm and stained with 1% toluidine blue to 
find the structure of interests. Then ultrathin sections (60 
nm) were cut, mounted on 200-mesh copper grids, and 
stained with uranyl acetate and lead citrate. Stained grids 
were examined under Philips CM-12 electron microscope 
and photographed with a Gatan (4k × 2.7k) digital cam-
era. To quantify mitochondria, at least 20 epithelial cells 
in each organoid were observed, and mitochondria were 
classified as type 1 (mitochondria whose cristae are main-
tained), type 2 (mildly swollen and a moderate decrease in 
the number of visible cristae), and type 3 (severely swol-
len and >70% of cristae are missing, or highly dysmorphic 
electron dense mitochondria).
Quantitative rt-Pcr
Total RNA was extracted from organoids at day 2 after lentivi-
ral transduction or at day 3 after crypt dissemination for Lgr5 
with TRIzol Reagent (Invitrogen) and cDNA was synthesized 
using ProtoScript First Strand cDNA Synthesis kit (NEB) ac-
cording to the manufacturer’s protocol. Quantitative PCR 
was performed on a Roche 480 II LightCycler. Gene expres-
sion was normalized to Gapdh using the following primers: 
Ripk3, 5′-AGG CTT CTA AAG CGA GTG ATGT-3′ and 5′-
TGA AGT CTT GTC TAC CAA CTC AGC-3′; Atg7, 5′-CAG 
TTT CCA GTC CGT TGA AGT CCT-3′ and 5′-GGG TCC 
ATA CAT CCA CTG AGG TTC-3′; Lgr5, 5′-CCT ACT CGA 
AGA CTT ACC CAG-3′ and 5′-GCA TTG GGG TGA ATG 
ATA GCA-3′; and Gapdh, 5′-TGG CCT TCC GTG TTC 
CTAC-3′ and 5′-GAG TTG CTG TTG AAG TCG CA-3′.
statistical analysis
GraphPad Prism version 7 was used for statistical analysis. Dif-
ferences between two groups were assessed using two-tailed 
unpaired Student’s t test when data were distributed normally; 
otherwise Mann-Whitney U test was used. An ANO VA with 
Tukey’s multiple-comparisons test was used to evaluate ex-
periments involving multiple groups. Survival was analyzed 
using the Mantel-Cox log-rank test.
online supplemental material
Fig. S1 shows additional analyses of Atg16L1ΔIEC mice sub-
jected to MNV+DSS or allo-HSCT and is related to Figs. 
1 and 2. Fig. S2 shows the effect of ATG16L1 deletion on 
small intestinal stem cells and colonic organoids and repre-
sentative pictures of PI staining and is related to Fig. 4. Fig. 
S3 shows additional analyses of the effect of Z-VAD and 
TNFα on Atg16L1ΔIEC organoids and the efficacy of Ripk3 
and Mlkl KD and is related to Fig. 5. Fig. S4 shows Western 
blotting analyses of necroptosis signaling molecules in organ-
oids and quantification of cell death in ATG7-deficient or-
ganoids and is related to Fig. 6. Fig. S5 shows quantification 
of cell death and Paneth cells in mice treated with Nec-1s and 
in vitro efficacy of GSK547 and is related to Fig. 8. Video 1 
shows live imaging analysis of organoids treated with TNFα 
and is related to Fig. 4.
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